Boosters

The U.S. FDA may soon authorize a spring round of COVID-19 boosters for some people

Mon, 2023-04-03 10:30 — mike kraft

The FDA may soon authorize a spring round of COVID-19 boosters for some people The Food and Drug Administration appears poised to make available the COVID-19 vaccines that target omicron as a second booster for people with weak immune systems and those ages 65 and older. NPR

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about The U.S. FDA may soon authorize a spring round of COVID-19 boosters for some people
Log in or register to post comments

SAGE updates COVID-19 vaccination guidance

Tue, 2023-03-28 15:48 — FNUOvviyaa

SAGE updates COVID-19 vaccination guidance Following its 20-23 March meeting, WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) revised the roadmap for prioritizing the use of COVID-19 vaccines, to reflect the impact of Omicron and high population-level immunity due to infection and vaccination. The roadmap continues SAGE’s prioritization of protecting populations at the greatest risk of death and severe disease from SARS-CoV-2 infection and its focus on maintaining resilient health systems. The roadmap newly considers the cost-effectiveness of COVID-19 vaccination for those at lower risk – namely healthy children and adolescents – compared to other health interventions. The roadmap also includes revised recommendations on additional booster doses and the spacing of boosters.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about SAGE updates COVID-19 vaccination guidance
Log in or register to post comments

WHO revises COVID-19 vaccine recommendations for Omicron-era

Tue, 2023-03-28 15:38 — FNUOvviyaa

WHO revises COVID-19 vaccine recommendations for Omicron-era The World Health Organization has tailored its COVID-19 vaccination recommendations for a new phase of the pandemic, suggesting that healthy children and adolescents may not necessarily need a shot but older, high-risk groups should get a booster between 6 to 12 months after their last vaccine. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO revises COVID-19 vaccine recommendations for Omicron-era
Log in or register to post comments

Do We Need a Spring COVID-19 Booster?

Tue, 2023-03-28 13:52 — FNUOvviyaa

Opinion | Do We Need a Spring COVID-19 Booster? A look at the data, particularly for high-risk groups Jeremy Faust, MD, and Katelyn Jetelina, PhD, MPH medpagetoday

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Do We Need a Spring COVID-19 Booster?
Log in or register to post comments

FDA offers radio silence on question of spring Covid boosters, as other countries push ahead

Sun, 2023-03-19 02:26 — FNUOvviyaa

FDA offers radio silence on question of spring Covid boosters, as other countries push ahead Canada and the U.K. are moving ahead with plans for spring Covid boosters for some individuals. In the U.S., the FDA's plans are unclear. Helen Branswell STAT

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA offers radio silence on question of spring Covid boosters, as other countries push ahead
Log in or register to post comments

Opinion: More investment is needed to counter evolving Covid: When will Congress fund updated Covid-19 treatments?

Tue, 2023-03-07 12:02 — mike kraft

Opinion: The clock is ticking. When will Congress fund updated Covid-19 treatments? | CNN Many antibody drugs are no longer effective against Covid-19 due to the rapid evolution of the virus and its many subvariants, writes Syra Madad. The US government desperately needs to continue to invest in more Covid therapeutics to keep up with the evolving nature of the virus. Syra Madad CNN

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Problem

Vulnerable people in UK to be offered spring Covid booster vaccine

Tue, 2023-03-07 11:26 — mike kraft

Vulnerable people in UK to be offered spring Covid booster vaccine Those eligible are being urged to come forward for the jab as infections remain high across UK the Guardian

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Vulnerable people in UK to be offered spring Covid booster vaccine
Log in or register to post comments

Monovalent COVID booster protects well against Omicron, but it wanes over 6 months --study

Fri, 2023-03-03 09:36 — mike kraft

Monovalent COVID booster protects well against Omicron, but it wanes over 6 months The COVID-19 booster was 74% effective against Omicron infection compared with the primary vaccine series for 3 months, but protection waned to 36% after 6 months. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Monovalent COVID booster protects well against Omicron, but it wanes over 6 months --study
Log in or register to post comments

Not enough data to support multiple annual COVID boosters, U.S. CDC advisory group says

Fri, 2023-02-24 17:18 — mike kraft

Not enough data to support multiple annual COVID boosters, U.S. CDC advisers say There is not sufficient evidence to recommend more than one COVID-19 booster shot a year for older people and those with weakened immune systems, an expert advisory group to the U.S. Centers for Disease Control and Prevention (CDC) said on Friday. Aditya Samal Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Not enough data to support multiple annual COVID boosters, U.S. CDC advisory group says
Log in or register to post comments

U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk

Thu, 2023-02-23 11:54 — mike kraft

CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk Advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday voted in favor of use of Bavarian Nordic's Jynneos vaccine for all adults at risk of mpox during an outbreak. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk
Log in or register to post comments

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

Boosters

The U.S. FDA may soon authorize a spring round of COVID-19 boosters for some people

SAGE updates COVID-19 vaccination guidance

WHO revises COVID-19 vaccine recommendations for Omicron-era

Do We Need a Spring COVID-19 Booster?

FDA offers radio silence on question of spring Covid boosters, as other countries push ahead

Opinion: More investment is needed to counter evolving Covid: When will Congress fund updated Covid-19 treatments?

Vulnerable people in UK to be offered spring Covid booster vaccine

Monovalent COVID booster protects well against Omicron, but it wanes over 6 months --study

Not enough data to support multiple annual COVID boosters, U.S. CDC advisory group says

U.S. CDC panel recommends Bavarian Nordic's mpox vaccine for all adults at risk

Pages

User login

Search form

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

Boosters

Pages